These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1042 related articles for article (PubMed ID: 17891215)

  • 1. The failure to diagnose inborn errors of metabolism in New Zealand: the case for expanded newborn screening.
    Wilson C; Kerruish NJ; Wilcken B; Wiltshire E; Webster D
    N Z Med J; 2007 Sep; 120(1262):U2727. PubMed ID: 17891215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening newborns for inborn errors of metabolism by tandem mass spectrometry.
    Wilcken B; Wiley V; Hammond J; Carpenter K
    N Engl J Med; 2003 Jun; 348(23):2304-12. PubMed ID: 12788994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of disorders of intermediary metabolism in New Zealand before and after expanded newborn screening: 2004-2009.
    Wilson C; Kerruish NJ; Wilcken B; Wiltshire E; Bendikson K; Webster D
    N Z Med J; 2012 Jan; 125(1348):42-50. PubMed ID: 22282276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of inborn errors of metabolism: disease spectrum for expanded newborn screening in Hong Kong.
    Lee HC; Mak CM; Lam CW; Yuen YP; Chan AO; Shek CC; Siu TS; Lai CK; Ching CK; Siu WK; Chen SP; Law CY; Tai HL; Tam S; Chan AY
    Chin Med J (Engl); 2011 Apr; 124(7):983-9. PubMed ID: 21542954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening of newborns for inborn errors of metabolism by tandem mass spectrometry].
    Simonsen H
    Ugeskr Laeger; 2002 Nov; 164(48):5607-12. PubMed ID: 12523003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.
    Wilcken B; Haas M; Joy P; Wiley V; Bowling F; Carpenter K; Christodoulou J; Cowley D; Ellaway C; Fletcher J; Kirk EP; Lewis B; McGill J; Peters H; Pitt J; Ranieri E; Yaplito-Lee J; Boneh A
    Pediatrics; 2009 Aug; 124(2):e241-8. PubMed ID: 19620191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report.
    Yoon HR; Lee KR; Kang S; Lee DH; Yoo HW; Min WK; Cho DH; Shin SM; Kim J; Song J; Yoon HJ; Seo S; Hahn SH
    Clin Chim Acta; 2005 Apr; 354(1-2):167-80. PubMed ID: 15748614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded newborn screening by tandem mass spectrometry: the Massachusetts and New England experience.
    Marsden D
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():111-4. PubMed ID: 15906712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New challenges to the Screening Center in the Bavarian State office for Health Care and Safe Quality of Foods].
    Nennstiel-Ratzel U; Arenz S; Wildner M; Kries RV; Liebl B
    Gesundheitswesen; 2004 Feb; 66 Suppl 1():S8-12. PubMed ID: 14770331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for inborn errors of metabolism: a systematic review.
    Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH
    Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
    Gleeson HK; Wiley V; Wilcken B; Elliott E; Cowell C; Thonsett M; Byrne G; Ambler G
    J Paediatr Child Health; 2008 Oct; 44(10):554-9. PubMed ID: 19012627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].
    Juan-Fita MJ; Egea-Mellado JM; González-Gallego I; Moya-Quiles MR; Fernández-Sánchez A
    Med Clin (Barc); 2012 Dec; 139(13):566-71. PubMed ID: 22137990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tandem mass spectrometry as screening for inborn errors of metabolism].
    Campos H D
    Rev Med Chil; 2011 Oct; 139(10):1356-64. PubMed ID: 22286738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal screening for congenital errors of metabolism by means of Tandem Mass: Italian experience].
    Cerone R; Cassanello M; Caruso U; Schiaffino MC; Lorini R
    Minerva Pediatr; 2007 Oct; 59(5):488-9. PubMed ID: 17947884
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical characteristics of neonates with inborn errors of metabolism detected by Tandem MS analysis in Oman.
    Joshi SN; Venugopalan P
    Brain Dev; 2007 Oct; 29(9):543-6. PubMed ID: 17314022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry.
    Tran K; Banerjee S; Li H; Noorani HZ; Mensinkai S; Dooley K
    Clin Biochem; 2007 Feb; 40(3-4):235-41. PubMed ID: 17222812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening: an overview.
    Carreiro-Lewandowski E
    Clin Lab Sci; 2002; 15(4):229-38. PubMed ID: 12776783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for inborn errors of metabolism using automated electrospray tandem mass spectrometry: study in high-risk Indian population.
    Nagaraja D; Mamatha SN; De T; Christopher R
    Clin Biochem; 2010 Apr; 43(6):581-8. PubMed ID: 20026021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening in Australia and New Zealand.
    Webster D; ;
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():69-70. PubMed ID: 15906698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.